PMID,Title,Journal,Year
37042420,The alteration of drug metabolism enzymes and pharmacokinetic parameters in nonalcoholic fatty liver disease: current animal models and clinical practice.,Drug metabolism reviews,2023
36233052,A Physiologically Based Pharmacokinetic Model to Predict the Impact of Metabolic Changes Associated with Metabolic Associated Fatty Liver Disease on Drug Exposure.,International journal of molecular sciences,2022
35777915,Gut microbiota and host Cyp450s co-contribute to pharmacokinetic variability in mice with non-alcoholic steatohepatitis: Effects vary from drug to drug.,Journal of advanced research,2022
35062050,CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver.,Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,2022
32795119,Omeprazole and Spirulina Platensis Ameliorate Steatohepatitis in Experimental Nonalcoholic Fatty Liver Disease.,Metabolic syndrome and related disorders,2020
28986475,Pediatric Cytochrome P450 Activity Alterations in Nonalcoholic Steatohepatitis.,Drug metabolism and disposition: the biological fate of chemicals,2017
28179883,New microRNA Biomarkers for Drug-Induced Steatosis and Their Potential to Predict the Contribution of Drugs to Non-alcoholic Fatty Liver Disease.,Frontiers in pharmacology,2017
27712037,In vivo cytochrome P450 activity alterations in diabetic nonalcoholic steatohepatitis mice.,Journal of biochemical and molecular toxicology,2017
